Literature DB >> 11112137

Peripheral and central ventilatory responses in central sleep apnea with and without congestive heart failure.

P Solin1, T Roebuck, D P Johns, E H Walters, M T Naughton.   

Abstract

Given that the apnea-ventilation cycle length during central sleep apnea (CSA) with congestive heart failure (CHF) is approximately 70 s, we hypothesized that rapidly responsive peripheral CO(2) ventilatory responses would be raised in CHF-CSA and would correlate with the severity of CSA. Sleep studies and single breath and rebreathe hypercapnic ventilatory responses (HCVR) were measured as markers of peripheral and central CO(2) ventilatory responses, respectively, in 51 subjects: 12 CHF with no apnea (CHF-N), 8 CHF with obstructive sleep apnea (CHF-OSA), 12 CHF-CSA, 11 CSA without CHF ("idiopathic" CSA; ICSA), and 8 normal subjects. Single breath HCVR was equally elevated in CHF-CSA and ICSA groups compared with CHF-N, CHF-OSA, and normal groups (0.58 +/- 0.09 [mean +/- SE] and 0. 58 +/- 0.07 versus 0.23 +/- 0.06, 0.25 +/- 0.04, and 0.27 +/- 0.02 L/min/PET(CO(2)) mm Hg, respectively, p < 0.001). Similarly, rebreathe HCVR was elevated in both CHF-CSA and ICSA groups compared with CHF-N, CHF-OSA, and normal groups (5.80 +/- 1.12 and 3.53 +/- 0. 29 versus 2.00 +/- 0.25, 1.44 +/- 0.16, and 2.14 +/- 0.22 L/min/PET(CO(2)) mm Hg, respectively, p < 0.001). Furthermore, in the entire CHF group, single breath HCVR correlated with central apnea-hypopnea index (AHI) (r = 0.63, p < 0.001) and percentage central/total apneas (r = 0.52, p = 0.022). Rebreathe HCVR correlated with awake Pa(CO(2)) (r = -0.61, p < 0.001), but not with central AHI or percentage central/total apneas independent of its relationship with single breath HCVR. In conclusion, in subjects with CHF, raised central CO(2) ventilatory response predisposes to CSA promoting background hypocapnia and exposing the apnea threshold to fluctuations in ventilation, whereas raised and faster-acting peripheral CO(2) ventilatory response determines the periodicity and severity of CSA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11112137     DOI: 10.1164/ajrccm.162.6.2002024

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  84 in total

Review 1.  Sleep in congestive heart failure.

Authors:  Bhavneesh Sharma; Robert Owens; Atul Malhotra
Journal:  Med Clin North Am       Date:  2010-05       Impact factor: 5.456

2.  Central sleep apnea indicates autonomic dysfunction in asymptomatic carotid stenosis: a potential marker of cerebrovascular and cardiovascular risk.

Authors:  Sven Rupprecht; Dirk Hoyer; Georg Hagemann; Otto W Witte; Matthias Schwab
Journal:  Sleep       Date:  2010-03       Impact factor: 5.849

3.  Carotid chemoreceptor modulation of sympathetic vasoconstrictor outflow during exercise in healthy humans.

Authors:  Michael K Stickland; Barbara J Morgan; Jerome A Dempsey
Journal:  J Physiol       Date:  2008-01-17       Impact factor: 5.182

4.  Indomethacin-induced impairment of regional cerebrovascular reactivity: implications for respiratory control.

Authors:  Ryan L Hoiland; Philip N Ainslie; Kevin W Wildfong; Kurt J Smith; Anthony R Bain; Chris K Willie; Glen Foster; Brad Monteleone; Trevor A Day
Journal:  J Physiol       Date:  2015-01-14       Impact factor: 5.182

5.  Breath-holding as a means to estimate the loop gain contribution to obstructive sleep apnoea.

Authors:  Ludovico Messineo; Luigi Taranto-Montemurro; Ali Azarbarzin; Melania D Oliveira Marques; Nicole Calianese; David P White; Andrew Wellman; Scott A Sands
Journal:  J Physiol       Date:  2018-07-06       Impact factor: 5.182

Review 6.  Respiratory sleep disorders in patients with congestive heart failure.

Authors:  Matthew T Naughton
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

7.  Left atrial size, chemosensitivity, and central sleep apnea in heart failure.

Authors:  Andrew D Calvin; Virend K Somers; Bruce D Johnson; Christopher G Scott; Lyle J Olson
Journal:  Chest       Date:  2014-07       Impact factor: 9.410

Review 8.  Cheyne-stokes respiration in patients with heart failure.

Authors:  Laila AlDabal; Ahmed S BaHammam
Journal:  Lung       Date:  2009-12-03       Impact factor: 2.584

9.  Improvement of idiopathic central sleep apnea with zolpidem.

Authors:  Syed Quadri; Christopher Drake; David W Hudgel
Journal:  J Clin Sleep Med       Date:  2009-04-15       Impact factor: 4.062

10.  The prevalence and natural history of complex sleep apnea.

Authors:  Shahrokh Javaheri; Jason Smith; Eugene Chung
Journal:  J Clin Sleep Med       Date:  2009-06-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.